×

Abuse-resistant amphetamine prodrugs

DC CAFC
  • US 7,700,561 B2
  • Filed: 04/10/2006
  • Issued: 04/20/2010
  • Est. Priority Date: 02/22/2002
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical composition comprising:

  • a. about 10 mg to about 250 mg of L-lysine-d-amphetamine or a pharmaceutically acceptable salt thereof;

    b. about 40% to about 90% by weight percent of microcrystalline cellulose;

    c. about 1% to about 10% by weight percent of croscarmellose sodium; and

    d. less than about 5% by weight percent of magnesium stearate.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×